Economía de los medicamentos genéricos en América Latina / Economy of generic drugs in Latin America
Rev. panam. salud pública
;
23(1): 59-67, ene. 2008.
Artículo
en Español
| LILACS
| ID: lil-478912
ABSTRACT
In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by examining various regulatory models in order to evaluate and leverage generic drug policy implementation options as a mechanism for battling some of the markets specific weaknesses. The conclusion is that there is no single unequivocal method for promoting the use of generic drugs, and that the most favorable way to integrate markets may be through a broad combination of alternatives. These alternatives are grouped and analyzed according to the market issues or challenges that must be overcome. Several options are then identified based on the degree of market consolidation to be obtained.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Medicamentos Genéricos
Tipo de estudio:
Estudios de evaluación
/
Evaluación Económica en Salud
Límite:
Humanos
Idioma:
Español
Revista:
Rev. panam. salud pública
Asunto de la revista:
Salud Pública
Año:
2008
Tipo del documento:
Artículo
País de afiliación:
Argentina
Institución/País de afiliación:
Universidad de Buenos Aires/AR
Similares
MEDLINE
...
LILACS
LIS